Navigation Links
Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
Date:10/14/2008

me, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

Contacts:

Dr. Jurgen Raths

President and CEO

Tel.: +41-61-417-96-60

Harry Welten, MBA

CFO and Senior Vice President

Tel.: +41-61-417-96-65

Paul Verbraeken

Head of Corporate Communications

Tel.: +41-61-417-96-83


'/>"/>
SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
2. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
3. Arpida Provides Further Comments on the Pivotal Phase III Trials
4. Arpida Invited to Present Data on Iclaprim at Scientific Conference
5. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
6. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
7. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
8. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
9. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
10. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
11. Burcon announces GRAS status for Puratein(R) & Supertein(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ... of Global Biologic Drug Discovery Outsourcing Market" report ... discovery outsourcing market will likely grow in a CAGR ... $11.4 B by 2020. It has been ... become a new but important type of medication. They ...
(Date:7/7/2015)... -- Dedicated to promoting wellness and giving back to its ... purple pledge in support of Alzheimer,s & Brain-Awareness Month. ... time to shine a purple light for the millions ... in our community who are affected by Alzheimer,s. Raising ... helps mobilize friends, family members, neighbors and coworkers to ...
(Date:7/7/2015)... , July 7, 2015 The ... USD 1,197.7 million by 2020, growing at an estimated CAGR ... study by Grand View Research, Inc. Introduction of innovative technologies ... with growing awareness levels pertaining to the advantages of breast ... next six years. In addition, presence of untapped growth opportunities ...
Breaking Medicine Technology:Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
(Date:7/7/2015)... ... July 07, 2015 , ... A June ... rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by the ... youthful than she has in some time and speculate that she might have ...
(Date:7/7/2015)... ... 2015 , ... Greatist today announced the acquisition of Blood, ... the most fun activities to do with friends. , The acquisition of BSC strengthens ... opportunity for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... only industry group whose board is limited to permit holders. The Medical Cannabis ... how to move the industry forward and are committed to making sure patients ...
(Date:7/7/2015)... ... ... June Pacific Prime Renewals team in Hong Kong announced that they were taking the ... Cotton, aims to not only reduce but eventually eliminate the use of paper in the ... 300 and 600 pieces of paper per month. Not to mention A4 sized envelopes used ...
(Date:7/7/2015)... Maryland (PRWEB) , ... July 07, 2015 , ... ... app to further enhance the experience for its patient community using its IDF ... app allows patients with primary immunodeficiency diseases (PI) to easily track their health ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... May 1 (HealthDay News) -- Children with juvenile arthritis ... children without arthritis, a new study says. While ... risk among kids with arthritis, other arthritis drugs -- ... were not. Researchers analyzed Medicaid data on ...
... May 1, 1012 AcademyHealth announced today the inaugural ... Services Researchers, which provides early career researchers with ... Meeting (ARM) and offers exclusive networking and mentoring ... leaders in the field. "The presidential scholarships ...
... (HealthDay News) -- Asthma often is misdiagnosed and undertreated in ... using prescribed inhalers, a small new study suggests. The ... asthma, who were over age 60. Of those with asthma, ... mites. The asthma patients were more likely than those ...
... In response to the considerable challenges in providing ... middle-income countries, policy makers, donors and program implementers are ... (the use of information communication technology for health) as ... a study in the May 1 issue of the ...
... Many asthmatic children in the United States are exposed to ... a new study shows. "National asthma guidelines have advised ... decades, but it is unclear to what degree these recommendations ... been in an era of increased awareness of the effects ...
... with asthma to avoid tobacco smoke, many youths are ... because of it, according to a study to be ... (PAS) annual meeting in Boston. "National asthma ... for patients with asthma for decades, but it is ...
Cached Medicine News:Health News:Arthritis in Children Linked to Infections 2Health News:First recipients of AcademyHealth's Presidential Scholarship announced 2Health News:New study identifies how information technology is used to solve global health challenges 2Health News:New study identifies how information technology is used to solve global health challenges 3Health News:Many Asthmatic Kids Harmed by Secondhand Smoke: Study 2Health News:Secondhand smoke continues to vex children with asthma 2
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: